Depression and heart failure  by Fauchier, Laurent
Taken together with our results, the mechanism of the beneficial
effect of torasemide in comparison with those of furosemide in the
TORIC study may be due to the presence of mineralocorticoid
receptor blocker in torasemide.
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Letters to the Editor
Depression and Heart Failure
We read with great interest the recent study by Gottlieb
et al. (1) and its related editorial (2) about the important problem
of depression in outpatients with heart failure (HF) evaluating its
prevalence and the impact of age, race, and gender. We would like
to add two comments.
First, we believe that the duration of evolution of HF symptoms
is a simple and important parameter that should have been taken
into account. A depression is likely to occur with time when the
patient realizes the true chronicle aspect of its disease, its severity,
and the overall limitation in physical activity and well-being. The
number of hospitalizations across the years may also play a role,
and these aspects of the disease might have been included in the
prediction model of Gottlieb et al. (1).
Second, the diagnosis of depression should particularly be
addressed when one considers the implantation of a cardioverter-
defibrillator (ICD). Although the device is usually well accepted
despite fear of being shocked, patients with an ICD have high levels
of anxiety and depressive symptoms (3). The ICD shocks might have
the potential to cause psychological disorders. This may become a
relatively frequent problem considering the preliminary results of the
Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT) in which
treatment with an ICD compared with placebo and amiodarone was
associated with a reduction in all-cause mortality in a large population
of patients with heart failure of all etiologies and with a left ventricular
ejection fraction 35% (4).
Thus, considering the potential association among ICD place-
ment, electrical shock from the ICD, and depression, we should
probably collect information regarding this association in the
evaluation of such patients.
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Figure 1. Plasma aldosterone (ALD) concentrations in the aortic root
(AO) and coronary sinus (CS) in patients with congestive heart failure. (A)
furosemide group; (B) torasemide group.
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Depression in Older
Adults With Heart Failure
We read with great interest the study by Gottlieb et al. (1), which
examined an important area in heart failure (HF) management:
depression. The investigators observed that for every 10 years
above the mean age (64 years), “the likelihood of exhibiting
depressive symptoms decreased by 26%.” This is surprising as
depression is rather common in old age. About 20% of the U.S.
population 65 years and older suffer from depression, compared
with 7% in younger adults (2,3).
Many of these older adults suffer from subsyndromal or atypical
depression, which is much more common in old age, more difficult
to diagnose, and is as distressing and disabling as major depression
(2–4). The vast majority of HF patients are 65 years or older, many
have preserved systolic function, and they receive care from
generalist physicians in nonacademic settings. The results of this
interesting study of depression in relatively younger male HF
patient with systolic dysfunction receiving care from a cardiology
clinic in an academic setting may not be generalizable to most HF
patients.
Focusing on “relatively young” patients may not be the most
efficient way to screen depression in HF, and certainly not in older
adults. In addition, use of the Geriatric Depression Scale, instead
of the Structured Clinical Interview described in theDiagnostic and
Statistical Manual of Mental Disorders, 3rd edition–Revised (DSM–
III-R) or other diagnostic tools such as Beck Depression Inven-
tory, is more likely to identify depression in older adults (5).
Finally, care settings also likely have significant implications for
appropriate diagnosis and management of depression in older
adults with HF. Older adults with HF should preferably receive
primary care from a generalist physician, in consultation with a
cardiologist (6). The American College of Cardiology/American
Heart Association guidelines for chronic HF has identified this
collaborative model as the most preferred model for HF manage-
ment (7).
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Influence of Age, Gender, and Race
on Depression in Heart Failure Patients
We applaud Gottlieb and colleagues for devoting attention to
depression and quality of life in heart failure (HF) patients (1). We
are concerned, however, with the investigators’ use of: 1) the Beck
Depression Inventory (BDI) (2) as a sole measure of depression,
and 2) the Medical Outcomes Study, Short Form Health
Survey-36 (SF-36) (3) as a measure of quality of life in HF
patients.
Although there is precedent for using the BDI to screen for
depression in HF patients (4,5), we are concerned that the BDI
may be inadequate as a single index of depression in this medically
ill population. Because the BDI was not designed to diagnose or
assess depression in medically ill patient samples, fully one-third of
the scale’s items are somatic in focus, assessing fatigue, appetite,
libido, sleep habits, somatic worry, functional ability, and weight
change—all symptoms consistent with HF. Previous studies of
major depression in HF have used the BDI as a screening
instrument before using a diagnostic interview such as the Diag-
nostic Interview Survey (DIS) (6) to diagnose major depression
(4,5). Without a diagnostic interview for depression and/or a
concurrent, nonsomatic measure of depression (e.g., the Hospital
Anxiety and Depression Scale) (7), using only the BDI to assess
depression poses a potential threat to construct validity in these
symptomatic HF patients. In their study, Gottlieb et al. (1) further
operationalized depression as a BDI score 10. Whereas Beck et
al. (2) categorize BDI scores of 4 to 10 as normal, and scores of 11
to 16 as indicative of mild depression, these cut-off points
represent norms established in a nonmedically ill population.
Thus, classifying stage II to IV HF patients with BDI scores 10
as depressed, in the absence of a secondary diagnostic or nonso-
matic measure of depression, may potentially serve to overestimate
the prevalence of depression in this, by definition, symptomatic
sample.
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